FDA Inspection
Northland Nuclear Medicine, LLCNorthland Nuclear Medicine, LLC – FDA Inspection, Jul 13, 2023
Record Details
This FDA Inspection record concerns Northland Nuclear Medicine, LLC, with an inspection on July 13, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b625c27f-5639-4afc-a90f-39876f36f744
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1210014
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 212.30(b)Equipment procedures
- 21 CFR 212.50Adequate controls (general)
- 21 CFR 212.50(b)(6)Action limits on radiochemical yield
- 21 CFR 212.30(b)Equipment procedures
- 21 CFR 212.50Adequate controls (general)
- 21 CFR 212.50(b)(6)Action limits on radiochemical yield
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Northland Nuclear Medicine, LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 7, 2019 | VAI | Minneapolis District Office | Generic Drug Evaluation |
Other documents for Northland Nuclear Medicine, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.